NeoDynamics appoints Decomplix as Swiss representative

The MedTech company NeoDynamics has appointed Decomplix as representative in Switzerland, to facilitate and ensure that its novel biopsy system NeoNavia meets all legal requirements in the local market.

Since late May 2022, Switzerland requires all foreign manufacturers that places medical devices on the Swiss market to appoint a Swiss Authorized Representative. The role of the representative is to be a point of contact with authorities, keep technical documentation at hand and support with vigilance inquires.

“Switzerland is set to be an important market for NeoDynamics, since it is a market where physicians strive to deliver care of exceptional quality. For us that translates into strong interest in our innovative pulse biopsy system NeoNavia,” says Renate Reiss, General Manager DACH.  “Europe is a critical region for the company as we have gained tremendous experience during the product’s clinical use.”

“We are very excited to represent NeoDynamics as Swiss Authorised Representative, facilitating their market access in Switzerland,” said Beni Hirt, Decomplix CEO.